REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Nov 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-11-15

Reporting Person: MURPHY ANDREW J (EVP Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-16	Common Stock	G	1645	$0.0	Disposed	55705	Direct
2021-11-15	Common Stock	M	16579	$52.03	Acquired	72284	Direct
2021-11-15	Common Stock	F	9412	$641.5	Disposed	62872	Direct
2021-11-16	Common Stock	S	465	$642.76	Disposed	62407	Direct
2021-11-16	Common Stock	S	924	$643.42	Disposed	61483	Direct
2021-11-16	Common Stock	S	1106	$644.71	Disposed	60377	Direct
2021-11-16	Common Stock	S	1640	$645.41	Disposed	58737	Direct
2021-11-16	Common Stock	S	557	$646.52	Disposed	58180	Direct
2021-11-16	Common Stock	S	844	$647.39	Disposed	57336	Direct
2021-11-16	Common Stock	S	86	$648.2	Disposed	57250	Direct
2021-11-16	Common Stock	S	5	$649.26	Disposed	57245	Direct
2021-11-16	Common Stock	S	296	$651.42	Disposed	56949	Direct
2021-11-16	Common Stock	S	133	$652.24	Disposed	56816	Direct
2021-11-16	Common Stock	S	454	$653.31	Disposed	56362	Direct
2021-11-16	Common Stock	S	198	$654.34	Disposed	56164	Direct
2021-11-16	Common Stock	S	92	$655.3	Disposed	56072	Direct
2021-11-16	Common Stock	S	74	$657.46	Disposed	55998	Direct
2021-11-16	Common Stock	S	71	$658.56	Disposed	55927	Direct
2021-11-16	Common Stock	S	155	$659.15	Disposed	55772	Direct
2021-11-16	Common Stock	S	67	$660.32	Disposed	55705	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-15	Non-Qualified Stock Option (right to buy)	$52.03	M	16579	Disposed	2021-12-16	Common Stock (16579)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4269	Indirect

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 465 shares of Company stock on November 16, 2021 at prices ranging from $642.35 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 924 shares of Company stock on November 16, 2021 at prices ranging from $643.07 to $643.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 1,106 shares of Company stock on November 16, 2021 at prices ranging from $644.24 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 1,640 shares of Company stock on November 16, 2021 at prices ranging from $645.01 to $645.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 557 shares of Company stock on November 16, 2021 at prices ranging from $646.12 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 844 shares of Company stock on November 16, 2021 at prices ranging from $647.09 to $647.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 86 shares of Company stock on November 16, 2021 at prices ranging from $648.15 to $648.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 296 shares of Company stock on November 16, 2021 at prices ranging from $651.00 to $651.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 133 shares of Company stock on November 16, 2021 at prices ranging from $652.22 to $652.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 454 shares of Company stock on November 16, 2021 at prices ranging from $653.04 to $653.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F12: Represents volume-weighted average price of sales of 198 shares of Company stock on November 16, 2021 at prices ranging from $654.07 to $654.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F13: Represents volume-weighted average price of sales of 92 shares of Company stock on November 16, 2021 at prices ranging from $655.20 to $655.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F14: Represents volume-weighted average price of sales of 155 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

F15: The stock option award vests in four equal annual installments, commencing one year after the date of grant.